The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CemiplimAb-rwlc survivorship and epidemiology (CASE): Interim results from a prospective study of the safety and effectiveness of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC) in a real-world setting.
 
Soo Park
Consulting or Advisory Role - Regeneron; Replimune
Research Funding - Regeneron (Inst); Replimune (Inst)
 
Guilherme Rabinowits
Consulting or Advisory Role - BioMedical Insights; BostonGene; Exelixis; Merck Serono; replimune; Sanofi/Regeneron
 
Timothy Panella
No Relationships to Disclose
 
Jade Homsi
Research Funding - Boehringer Ingelheim; Regeneron
Expert Testimony - Thornton Biechlin
 
Emily Ruiz
Consulting or Advisory Role - Checkpoint Therapeutics; Genentech; Leo Pharma; Regeneron
Research Funding - PellePharm; Regeneron
 
David Ellison
Stock and Other Ownership Interests - Bristol-Myers Squibb; Illumina; Janssen; Merck; Pfizer
 
Michael Kelley
Research Funding - Bristol-Myers Squibb (Inst); EQRx (Inst); Genentech (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Regeneron (Inst)
 
Yvonne Saenger
Consulting or Advisory Role - Regeneron
Research Funding - Nextpoint Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Patent for a gene signature for melanoma prognosis
 
Richard Zuniga
Consulting or Advisory Role - Bristol-Myers Squibb; Chemo Mouthpiece; Mirati Therapeutics
 
Cong Zhu
Employment - Regeneron
Stock and Other Ownership Interests - Regado Biosciences
 
Debra McIntyre
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Ruben Quek
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Joy Wang
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Kathryn Gillis
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Jean-Francois Pouliot
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Nikhil Khushalani
Stock and Other Ownership Interests - Amarin Corporation; Asensus Surgical; Bellicum Pharmaceuticals
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Castle Biosciences; Genzyme; Immunocore; Incyte; Instil Bio; IO Biotech; Iovance Biotherapeutics; Jounce Therapeutics; Merck; NCCN/Pfizer; Nektar; Novartis; Regeneron; Replimune
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); HUYA Bioscience International (Inst); IDEAYA Biosciences (Inst); Merck (Inst); Modulation Therapeutics (Inst); Novartis (Inst); Regeneron (Inst); Replimune (Inst)
Travel, Accommodations, Expenses - Castle Biosciences; Regeneron
Other Relationship - Bristol-Myers Squibb/Celgene; Nektar; Regeneron; Replimune; T-knife Therapeutics